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When telomeres become critically short, DNA
damage response factors are recruited at chromo-
some ends, initiating a cellular response to DNA
damage. We performed proteomic isolation of
chromatin fragments (PICh) in order to define
changes in chromatin composition that occur
upon onset of acute telomere dysfunction triggered
by depletion of the telomere-associated factor
TRF2. This unbiased purification of telomere-
associated proteins in functional or dysfunctional
conditions revealed the dynamic changes in chro-
matin composition that take place at telomeres
upon DNA damage induction. On the basis of our
results, we describe a critical role for the polycomb
group protein Ring1b in nonhomologous end-
joining (NHEJ)-mediated end-to-end chromosome
fusions. We show that cells with reduced levels of
Ring1b have a reduced ability to repair uncapped
telomeric chromatin. Our data represent an unbi-
ased isolation of chromatin undergoing DNA dam-
age and are a valuable resource to map the changes
in chromatin composition in response to DNA dam-
age activation.INTRODUCTION
Most human cancer cells have short telomeres when compared
to normal surrounding tissues (Hastie et al., 1990; Meeker et al.,
2004). This is due to the relatively late reactivation of telome-
rase during tumorigenesis, resulting in the proliferation of cells
for an extended period of time in the absence of a telomere
elongation mechanism (Maser and DePinho, 2002; Shay and
Wright, 2001). Loss of end protection is frequently detected in
human cancers such as colorectal carcinomas (Rudolph
et al., 2001), oral squamous cell carcinomas (Gordon et al.,
2003), and chronic lymphocytic leukemia (Augereau et al.,1320 Cell Reports 7, 1320–1332, May 22, 2014 ª2014 The Authors2011; Chin et al., 2004; Lin et al., 2010; Suram et al., 2012).
Mounting evidence suggests that telomere dysfunction plays
a crucial role in promoting tumor development (Ramsay et al.,
2013). For example, the induction of telomere dysfunction in
mice results in epithelial cancers with a complex karyotype,
indicative of rampant genomic instability (Artandi et al., 2000;
Chin et al., 1999). The most striking illustration of the role of
end protection in human health comes from patients affected
by the rare inherited disorder dyskeratosis congenita (DC).
This disease is caused by mutations affecting either telomere
elongation factors (dyskerin and hTERT) or telomere-associ-
ated proteins (Dokal, 2000; Kirwan and Dokal, 2009; Mitchell
et al., 1999; Sarper et al., 2010; Shay and Wright, 1999; Touzot
et al., 2010; Vulliamy et al., 2004; Walne et al., 2008). Among
other symptoms, DC patients have critically short telomeres,
show signs of telomere dysfunction, and display an increased
incidence of cancer.
When telomeres become critically short, they fail to recruit
sufficient levels of protective shelterin complex, resulting in
failure to protect chromosome ends and leading to the
activation of a DNA damage response (DDR) pathway
(d’Adda di Fagagna et al., 2003; Takai et al., 2003). Indeed,
to date, the following DNA damage proteins have been
shown to play a role in the response to dysfunctional telo-
meres: MRE11, ATM, gH2AX, MDC1, RNF8, RNF168, 53BP1,
RIF1, and PTIP1 (Attwooll et al., 2009; Chapman et al., 2013;
Denchi and de Lange, 2007; Di Virgilio et al., 2013; Dimitrova
et al., 2008; Dimitrova and de Lange, 2006, 2009; Peuscher
and Jacobs, 2011; Zimmermann et al., 2013). However, a
global approach to systematically determine which factors
relocalize to or from dysfunctional telomeres is currently
lacking.
Here, we applied a proteomic approach to comprehensively
characterize the proteins whose localization changes upon telo-
mere dysfunction. Using this approach, we identified a series of
previously characterized DDR factors as telomere-dysfunction-
recruited factors in addition to a set of factors that are recruited
to dysfunctional telomeres. In addition, our data revealed a crit-
ical role for the polycomb protein Ring1b for the efficient nonho-
mologous end-joining (NHEJ)-mediated fusion of dysfunctional
telomeres.
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Figure 1. Proteomics of Isolated Chromatin
Segments of Functional and Dysfunctional
Mouse Telomeres
(A) Schematic representation of the PICh analysis
employed to define the chromatin changes that
occur at telomeres upon TRF2 depletion.
(B) Identified proteins were plotted based on the
log2 intensity (y axis) calculated based on the total
spectra counts identified and ratio between TRF2-
proficient and TRF2-deficient settings (x axis)
calculated as log2 (OHT spectra/control spectra).
Only proteins identified in at least two experiments
are plotted. Green and orange dots represent
proteins recruited at telomeres in a TRF2-depen-
dent or TRF2-independent manner, respectively.
Yellow dots represent known DNA damage factors
recruited to dysfunctional telomeres.
(C) Venn diagrams depicting the total number of
proteins identified in at least two out of three PICh
experiments from the control and OHT samples
and the degree of overlap between the data sets
from the two samples.
(D) Table listing shelterin components and some of
the DNA damage response (DDR) factors identified
with the corresponding spectra counts isolated in
each individual experiment. nd, not detected.
(E) Pie chart illustrating the distribution of proteins
identified in the TRF2-depleted samples (OHT),
classified according to Gene Ontology (GO). Note
the enrichment for DNAdamage response proteins.RESULTS
Changes in Chromatin Composition following Telomere
Dysfunction
We hypothesized that upon acute telomere dysfunction, relocal-
ization of DDR factors at telomeric repeats [TTAGGG]n would
lead to a drastic change in chromatin composition at chromo-
some ends and that this could be isolated and identified using
an unbiased proteomic approach. To verify this hypothesis, we
adapted a technique termed PICh (proteomics of isolated chro-
matin segments) that allows the isolation of chromatin regions
using a biotinylated oligonucleotide complementary to a DNA
sequence of interest (De´jardin and Kingston, 2009). PICh was
originally designed to isolate telomeric chromatin derived from
human cells and employed locked nucleic acid (LNA)-modified
oligos. We optimized several steps in the PICh protocol in order
to efficiently isolate telomeric chromatin from murine cells
including the use of peptide nucleic acid (PNA)-modified oligo-
nucleotides as capture probes. In our experiments, the use of
PNA probes resulted in more efficient isolation of telomeric chro-
matin when compared to LNA-modified oligonucleotides (data
not shown). To achieve synchronous and homogenous telomere
dysfunction, we used TRF2 conditional knockout mouse embry-
onic fibroblasts (MEFs) (Celli and de Lange, 2005) harboring
an inducible CRE recombinase (Rosa26-CRE-ER) (previously
described in Okamoto et al., 2013). 4-Hydroxytamoxifen (OHT)
treatment of these cells allows for efficient and synchronous
deletion of TRF2, resulting in DNA damage activation at every
chromosome end (Okamoto et al., 2013). Telomeric chromatinCwas isolated using a PNA capture probe complementary to the
telomeric repeat sequence [TTAGGG]3 conjugated with a des-
thiobiotin moiety (see Figure 1A for schematics). Telomeric
chromatin was isolated in three independent experiments from
TRF2-depleted (OHT) and control cells. The resulting chro-
matin-associated proteins were identified using liquid chroma-
tography tandem mass spectrometry, and only proteins
identified in at least two independent experiments were further
analyzed. In total, we identified 787 unique proteins in samples
derived from TRF2-proficient cells and 559 in samples derived
from TRF2-deficient cells (Figure 1; Table S1). Importantly,
despite the different cellular systems used, there is 60% of over-
lap between the proteins that we identified in TRF2-proficient
MEFs and the ones isolated in HeLa cells (De´jardin and Kingston,
2009). In support of our initial hypothesis, we found significant
differences in the composition of telomeric chromatin in the
presence or absence of TRF2, with 316 proteins found only at
TRF2-proficient telomeres, 88 proteins found only at TRF2-defi-
cient telomeres, and 471 proteins found in both conditions
(Figure 1C). Among the proteins that were only found at TRF2-
proficient telomeres, we found TRF2 and its binding partners
RAP1 and Apollo (Lenain et al., 2006; van Overbeek and de
Lange, 2006; Li et al., 2000) (Figures 1B–1D; Table S2). In
contrast, from TRF2-deficient telomeres, we isolated several
DNA damage factors that have been previously shown to localize
to dysfunctional telomeres such as ATM, the MRE11 complex,
MDC1, and 53BP1 (Celli and de Lange, 2005; Dimitrova and de
Lange, 2006) (Figures 1B–1D; Table S3). Finally, proteins that
are known to bind to telomeres in a TRF2-independent mannerell Reports 7, 1320–1332, May 22, 2014 ª2014 The Authors 1321
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Figure 2. Validation of Factors that Localize at Dysfunctional Telomeres
(A) List of proteins identified by PICh as enriched at dysfunctional telomeres. Average number of spectra identified at TRF2-deficient (OHT) or TRF2-proficient (NT)
telomeres is indicated. Proteins were ranked based on their relative enrichment at TRF2-depleted telomeres and normalized to absolute expression of the protein
(legend continued on next page)
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were not significantly enriched in either sample, such as the shel-
terin components (TRF1, TIN2, TPP1, POT1a, and POT1b) and
other known telomere-associated proteins, such as members
of the STN1 and THO complexes and the chromatin-remodeling
factors ATRX and DAXX (Figures 1B–1D; Table S1) (Buscemi
et al., 2004; de Lange, 2005; Lewis et al., 2010; Pfeiffer et al.,
2013; Wong et al., 2010). Annotation of the proteins found only
in the TRF2-depleted setting revealed a significant enrichment
for DDR genes (Figure 1E). Collectively, our data show that using
a PICh-based approach, we were able to detect the changes
that occur in chromatin upon removal of the telomeric factor
TRF2 and the consequent induction of a DNA damage response
at uncapped chromosome ends.
Isolation of Proteins that Are Displaced from
Dysfunctional Telomeres
To define the critical changes that occur in telomeric chromatin
upon removal of TRF2, we first focused on the proteins that
were lost upon OHT treatment. To this end, proteins with signif-
icant telomeric enrichment in TRF2-proficient cells relative to
OHT-treated controls were ranked based on their absolute
expression in mouse cells using the online database PaxDB
(Wang et al., 2012). In addition, the resulting lists were run
against the Contaminant Repository for Affinity Purification
(http://www.crapome.org) (Mellacheruvu et al., 2013), and com-
mon contaminants were excluded from further analysis. Signifi-
cantly, the list of proteins that are lost upon TRF2 depletion
contained at top-ranking positions RAP1 and Apollo, two pro-
teins that have been shown to be recruited at telomeres in a
TRF2-dependent manner (Celli and de Lange, 2005; Lenain
et al., 2006; Li et al., 2000; van Overbeek and de Lange, 2006),
as well as TRF2 (Table S2). To validate additional factors that
are lost from telomeres upon TRF2 depletion, we chose two
proteins among the top 5% of the factors enriched at TRF2-pro-
ficient telomeres: LRWD1 and CDCA8. Localization of these pro-
teins at telomeres was tested in the presence or absence of
TRF2 using tagged alleles expressed from retroviral vectors in
TRF2F/F Rosa26 CRE-ER MEFs. As a positive control, we used
a myc-tagged RAP1 allele. Our results indicate that CDCA8
and LRWD1 showed frequent colocalization with telomeric
DNA (Figures S1A and S1B). In agreement with our PICh results,
we found that upon TRF2 depletion, the localization of CDCA8
with telomereswas reduced by approximately 50% (Figure S1B).
On the contrary, LRWD1 localization to telomeres was not
significantly affected by the loss of TRF2, suggesting that its
recruitment to telomeres is independent of TRF2 (Figure S1B).
Therefore, these data suggest that our analysis can detect
both known and unidentified telomere-associated factors that
are affected by TRF2 depletion. Interestingly, LRWD1 was also
recently identified at telomeres in a quantitative proteomicin mouse cells (PaxDB database). Proteins highlighted in yellow represent DNA da
highlighted in blue represent proteins selected for validation.
(B) Localization of ectopically expressed tagged proteins (myc/GFP) (stained in r
MEFs infected with the indicated constructs were treated with OHT and harvest
(C) Quantification of data shown in (B). Cells with five or more foci colocalizing w
three independent experiments.
See also Figure S2.
Capproach performed by the Lingner laboratory (Grolimund
et al., 2013). To address whether CDCA8 and/or LRWD1 play a
critical role in telomere protection, we performed small hairpin
RNA (shRNA) depletion of these proteins. Efficient downregula-
tion of either CDCA8 or LRWD1 did not result in accumulation
of the DNA damage factors gH2AX and 53BP1 at telomeres (Fig-
ures S1C–S1E). In contrast, shRNA-mediated downregulation of
TRF2 resulted in frequent localization of gH2AX and 53BP1 foci
at chromosome ends (Figures S1C–S1E). CDCA8 is part of the
chromosome passenger complex (CPC), which is involved in
proper mitotic segregation and cytokinesis (reviewed in Car-
mena et al., 2012). LRWD1 mediates association of the origin
recognition complex (ORC) to chromatin and was shown to be
required for the maintenance of pericentric heterochromatin
silencing (Chan and Zhang, 2012; Shen et al., 2010). Although
depletion of these proteins did not result in activation of a DNA
damage response at TRF2-depleted telomeres, we could not
exclude that CDCA8 and/or LRWD1 have a role at telomeres
that was not detected by our analyses, and further functional
characterization is currently undergoing and will be reported in
a future study.
Isolation of Proteins that Are Recruited to Dysfunctional
Telomeres
Next, we focused on factors that are recruited to telomeres
following TRF2 loss. Proteins were ranked based on their relative
enrichment at dysfunctional telomeres and normalized to their
absolute expression inmouse cells (Wang et al., 2012). This anal-
ysis revealed 114 proteins that are enriched at TRF2-depleted
telomeres. Among these proteins, we found 24 known DDR
proteins, of which ten were previously reported to be associated
with dysfunctional telomeres (Figure 2A; Table S3). To validate
whether our approach identified factors that relocalize to
dysfunctional telomeres, we selected 15 proteins ranked at
different positions within this list and tested their localization in
the presence or absence of TRF2 (Figure 2). The selected factors
represented both proteins that were previously shown to interact
withDNAdamage sites aswell as proteinswith no reported link to
the DDR pathway. TRF2F/F Rosa26 CRE-ER MEFs expressing a
tagged version of the selected proteins were treated with tamox-
ifen (OHT) or left untreated (control), and the localization of the
ectopically expressed proteins to telomeric DNA was assessed
by indirect immunofluorescence (IF). As a positive control, we
used a 53BP1 allele that has been previously shown to localize
to dysfunctional telomeres (Dimitrova et al., 2008). As expected,
ectopically expressed 53BP1 colocalized with telomeres in the
vast majority of TRF2-deficient cells (Figures 2B and 2C). Simi-
larly, eight of the selected proteins (Rad18, Rap80, Senp7,
Ring1b, Pml, Fam50a, Fancd2, and Ppp2r5d) localized at telo-
meres upon TRF2 depletion, while the remaining seven showedmage response factors known to localize at dysfunctional telomeres. Proteins
ed) to telomere repeats (TTAGGG, stained in green). TRF2F/F Rosa26 CRE-ER
ed 3 days later. Scale bar represents 5 mm.
ith telomeres were counted as positive. Error bars represent SD of average of
ell Reports 7, 1320–1332, May 22, 2014 ª2014 The Authors 1323
A B
C D E
Figure 3. Ring1b Plays a Critical Role in the Response to Dysfunctional Telomeres
(A) Metaphase spreads were harvested from TRF2F/F Rosa26 CRE-ERMEFs infected with a control lentiviral construct (shLuciferase) or with the indicated shRNA
constructs and treated with OHT for 96 hr. Chromosomes were stained with a PNA probe complementary to telomeric repeats (green) and DAPI (red).
Percentages of fused chromosome ends are indicated. Scale bar represents 5 mm.
(B) Quantification of data shown in (A).
(C) TRF2F/F Rosa26 CRE-ERMEFs infected with the indicated shRNA constructs were treated with OHT for 72 hr and fixed and stained for gH2AX (green), 53BP1
(red), and DAPI (blue). Scale bar represents 5 mm.
(D) Quantification of the data shown in (C) (cells with five or more gH2AX/53BP1 foci were counted as positive). Error bars represent SD of average of three
independent experiments.
(E) Quantification of relativemRNA levels of the indicated genes in cells infectedwith the indicated shRNA constructs, normalized to shLuciferase as control. Error
bars represent SD of the average of three independent experiments.
See also Figure S3.either no detectable colocalization or a diffuse nuclear staining
(Figures 2B and 2C). Nucleoplasmic extraction experiments re-
vealed tight association of Rad18, Rap80, Pml, Senp7, Ring1b,
and Fancd2 with dysfunctional telomeres (Figure S2).
A Role for Ring1b in the Onset of End-to-End
Chromosome Fusions
TRF2-depleted cells undergo dramatic end-to-end chromosome
fusions (Celli and de Lange, 2005). To test whether any of the fac-1324 Cell Reports 7, 1320–1332, May 22, 2014 ª2014 The Authorstors identified at TRF2-depleted telomeres plays a role in this
process, we infected cells with specific shRNAs and tested the
frequency of end-to-end chromosome fusions on metaphase
spreads (Figure 3A). As a positive control, we used an shRNA
directed against MDC1 that results in reduced levels of NHEJ-
mediated telomere fusions (Dimitrova and de Lange, 2006).
Strikingly, this analysis revealed that cells with reduced Ring1b
expression showed approximately a 50% reduction in the rate
of NHEJ-mediated telomere fusions (Figures 3A, 3B, and 3E).
In contrast, efficient knockdown of Rad18, Rap80, or Senp7 did
not show a significant effect on the rate of telomere fusions. The
effect of Ring1b on telomere fusion was further confirmed using
telomere restriction fragment (TRF) analysis on Southern blots
(Figure S3A). Importantly, we exclude that the observed defect
in NHEJ efficiency reflects an alteration in cell-cycle progression
caused by reduced Ring1b levels based on fluorescence-acti-
vated cell sorting (FACS) analysis (Figure S3B). To test whether
the NHEJ defects observed upon Ring1b depletion could be
due to altered DNA damage signaling at TRF2-deficient
telomeres, we tested the induction of phosphorylated H2AX
(gH2AX) and recruitment of 53BP1 in the TRF2F/F Rosa26
CRE-ER cells treated with tamoxifen and infected with the
shRNA construct against Ring1b. As a control, we used a previ-
ously validated shRNA against MDC1 that affects the recruit-
ment of 53BP1 at TRF2-depleted telomeres (Dimitrova and de
Lange, 2006). Knockdown of Ring1b had no significant effect
on the dynamics of gH2AX or 53BP1 to TRF2-depleted telo-
meres, while depletion of MDC1 resulted in impaired recruitment
of 53BP1 as previously described (Figures 3C–3E). In addition,
Ring1b depletion did not impair recruitment of the 53BP1 down-
stream effector RIF1 (Chapman et al., 2013; Escribano-Dı´az
et al., 2013; Zimmermann et al., 2013) to dysfunctional telo-
meres, excluding that the NHEJ defects observed in Ring1b-
depleted cells are due to impaired RIF1 recruitment (Figures
S3C and S3D). These experiments suggest that Ring1b might
play a role at dysfunctional telomeres independent of the dy-
namics of gH2AX and 53BP1 at these sites.
To exclude the possibility that the observed phenotype is
caused by an off-target effect, we generated an shRNA-resistant
allele of Ring1b (Ring1b-WT*). Expression of Ring1b-WT* in
TRF2-deficient cells infected with shRing1b rescued the NHEJ
defects, thus excluding potential off-target effects (Figures 4A
and S4A). Ring1b is a RING finger E3 ubiquitin ligase of the poly-
comb repressive complex 1 (PRC1) that acts in concert with
Bmi1 to ubiquitinate histone H2A on K119 (H2AK119ub), via its
RING finger domain, and to promote gene silencing and chro-
matin compaction (Cao et al., 2005; Stock et al., 2007; Vidal,
2009; Wang et al., 2004). In agreement with our observation
that Ring1b localizes to chromosome ends, we observed an
enrichment of the H2AK119ub mark at telomeres compared to
other genomic loci by chromatin immunoprecipitation (ChIP)
(Figures S4B–S4D). To test whether the enzymatic activity of
Ring1b is required to promote NHEJ at TRF2-depleted cells,
we complemented Ring1b-depleted cells with an shRNA-resis-
tant, catalytically inactive mutant allele of Ring1b carrying a
mutation in the RING domain (Ring1b-I53A*) (Buchwald et al.,
2006). Expression of Ring1b-I53A* in TRF2-deficient cells res-
cues the NHEJ defect observed in the absence of Ring1b to
levels that are comparable to ones observed in cells expressing
the wild-type Ring1b-WT* allele (Figures 4A and S4A). These
data indicate that the catalytic activity of Ring1b is dispensable
for its role in promoting NHEJ at dysfunctional telomeres.
Next, we tested whether inhibition of Ring1b binding partner
Bmi1 by shRNA would affect NHEJ-mediated telomere fusions.
Indeed, expression of two independent shRNA constructs
directed against Bmi1 resulted in a significant reduction in the
rate of telomere fusions in TRF2 null cells (Figures 4B and 4C).CBmi1 inhibition did not affect phosphorylation of H2AX or recruit-
ment of 53BP1 at TRF2-depleted telomeres (Figure 4D), similarly
to what was observed for the inhibition of Ring1b.
To further confirm our findings, we testedwhether cells lacking
Ring1b would exhibit defects in NHEJ-mediated repair of telo-
meres. Expression of a dominant-negative allele of TRF2 in
Ring1bF/F; Rosa26 CRE ER MEFs resulted in DNA damage
activation at telomeres in both Ring1b-deficient and Ring1b-
proficient cells (Figures 4E and S4E–S4G). In contrast, the occur-
rence of end-to-end chromosome fusions upon expression of
the TRF2 dominant-negative allele was severely reduced in
Ring1b-deficient cells (Figure 4F).
Our results suggest that the presence of the heterodimer
Ring1b-Bmi1 is required for efficient NHEJ at chromosome
ends.
Ring1b Plays a Critical Role for Efficient DNA Repair of
Heterochromatin Loci
Next, we asked whether Ring1b-deficient cells show defective
DNA repair throughout the genome. Ring1b null cells were
treated with gamma irradiation to induce random DNA damage.
As controls, we used wild-type cells and NHEJ-defective cells
(Lig4 null) (Ku¨hne et al., 2004). DNA repair efficiencywas assayed
by fraction of activity released (FAR) assay (Gulston et al., 2002)
(Figures S5A and S5B). Our results show that Ring1b null cells do
not show any significant defect in DNA repair when compared to
wild-type cells. In contrast, Lig4 null cells displayed the expected
defect in DNA repair (Figures S5A and S5B). Next, we asked
whether Ring1b activity is required for the repair of DNA damage
occurring at other heterochromatin loci. To test this hypothesis,
we irradiated Ring1bF/F; Rosa26 CRE ER MEFs and assayed
cells for the persistence of the DNA damage marker gH2AX
over time at ‘‘chromocenters,’’ cytological distinct structures
that correspond to pericentric and centromeric heterochromatin
(Guenatri et al., 2004). As a control, we included ATM/ cells
that were previously shown to have a defect in DNA repair at het-
erochromatin loci (Goodarzi et al., 2008). Our results show that
Ring1b null cells, similarly to ATM/ cells, show a significant
persistence of heterochromatin-associated gH2AX foci at 6 hr
after irradiation (Figures 5A and 5B). These data suggest that
Ring1b activity is required for efficient repair of DNA damage
occurring at heterochromatin loci. Notably, at 24 hr postirradia-
tion, Ring1b/ cells repaired most DNA damage lesions as
assessed by gH2AX foci dissipation. In agreement with the
FAR assay data, Ring1b/ cells did not show a defect in DNA
repair at nonheterochromatin loci, as shown by the dissipation
of gH2AX foci throughout the nuclei (Figure S5C). In conclusion,
our data suggest that the role of Ring1b in DNA repair is specific
for heterochromatin loci.
Chromatin Compaction Activity Plays an Important Role
for Efficient DNA Repair of Dysfunctional Telomeres
Ring1b is associated to chromatin compaction and gene
silencing (Vidal, 2009) and has been shown to be required for
the maintenance of a compact chromatin state atHox loci in em-
bryonic stem cells (Eskeland et al., 2010). The chromatin context
in whichDNAdamage occurs has amajor impact on the pathway
and the efficiency of DNA repair activities, with closed chromatinell Reports 7, 1320–1332, May 22, 2014 ª2014 The Authors 1325
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favoring the NHEJ pathway (Chiolo et al., 2011;Miller et al., 2010;
Soria et al., 2012). We therefore hypothesized that reduced
levels of Ring1b could lead to reduced levels of DNA repair at
telomeres due to changes in the heterochromatic state. To test
this hypothesis, we treated TRF2F/F Rosa CRE-ER MEFs with
the histone deacetylase (HDAC) inhibitor trichostatin A (TSA) to
decompact chromatin. TSA treatment did not have a significant
effect on the recruitment of 53BP1 to TRF2-depleted telomeres
(Figure S5D). However, TSA treatment significantly reduced the
percentage of telomere fusions (Figure 5C). FACS analysis
excluded that TSA treatment affects NHEJ indirectly by altering
cell-cycle progression (Figure S5E).
To further validate our hypothesis that loss of chromatin
compaction would result in reduction of NHEJ at dysfunctional
telomeres, we used Suv39 double-null (dn) MEFs (Peters et al.,
2001). The lysine methyltransferases (KMTs) Suv39h1 and
Suv39h2 govern H3K9 trimethylation at pericentric heterochro-
matin (Peters et al., 2001) and were shown to be important for
H3K9me3 deposition at telomeres (Garcı´a-Cao et al., 2004).
The presence of trimethylated histone H3 (H3K9me3) is a hall-
mark of mammalian heterochromatin (Bannister et al., 2001;
Lachner et al., 2001; Rea et al., 2000). Suv39 dn cells display
loss of heterochromatic features such as loss of heterochromatic
association of HP1 proteins and partial decondensation of het-
erochromatic foci (Lachner et al., 2001; Pinheiro et al., 2012).
Expression of a dominant-negative allele of TRF2 in Suv39 dn
MEFs also resulted in a lower occurrence of end-to-end chromo-
some fusions relative to the wild-type control (Figures S5F
and S5G). Moreover, shRNA-mediated depletion of the KMT
Prdm3, which was shown to prevent Suv39h-mediated H3K9
trimethylation resulting in chromatin decompaction at mouse
chromocenters (Pinheiro et al., 2012), significantly reduced the
percentage of fused chromosomes in TRF2-deficient cells rela-
tive to control cells (Figures 5D and S5H).
Collectively, these results suggest that chromatin compaction
is a critical determinant for the frequent occurrence of NHEJ-
mediated fusions at dysfunctional telomeres (see schematic
model in Figure 5E).
DISCUSSION
Our data reveal the dynamic changes that occur at the level of
chromatin upon the induction of DNA damage at mammalian
telomeres. We identified 345 factors that are significantly lostFigure 4. The Ring1b/Bmi1 Heterodimer Acts on the Chromatin at Dys
(A) Metaphase spreads of TRF2F/F Rosa26 CRE-ER MEFs infected with shLucife
96 hr. Percentages of fused chromosome ends are indicated. Scale bar represe
(B) Metaphase spreads of TRF2F/F Rosa26 CRE-ER MEFs infected with shRNA co
fused chromosome ends are indicated. Scale bar represents 5 mm. Graph show
normalized to shLuciferase as control.
(C) Quantification of end-to-end chromosome fusions in (B).
(D) Quantification of gH2AX- and 53BP1-positive TRF2F/F Rosa26 CRE-ERMEFs i
gH2AX and 53BP1 (cells with five or more gH2AX/53BP1 were counted as posit
(E) Ring1bF/F Rosa26 CRE-ER MEFs (/+ OHT, 96 hr) were infected with wild-typ
and stained for myc (red), 53BP1 (green), and DAPI (blue). Scale bar represents
(F) Metaphase spreads of Ring1bF/F Rosa26 CRE-ER MEFs treated as in (E) were
(arrowheads). Number of metaphases analyzed and percentage of metaphases
See also Figure S4.
Cupon TRF2 depletion at telomeric chromatin. These included
TRF2 and its associated proteins RAP1 and Apollo. In addition,
we identified one factor, CDCA8, that is significantly affected
by the removal of TRF2. We identified 471 factors that are pre-
sent at telomeres regardless of the TRF2 status. These factors
included DNA metabolism genes such as histones, DNA poly-
merases, and telomere-associated proteins that can be re-
cruited to telomeric repeats independently of TRF2 such as the
shelterin components TRF1, TIN2, TPP1, and POT1 and the telo-
mere-associated factors ATRX and DAXX (Lewis et al., 2010;
Wong et al., 2010). Finally, our isolation identified several known
DNA damage response factors that relocalize to telomeres
following TRF2 deletion and several additional proteins that
were not previously associated with the response to telomere
dysfunction. Our validation identified eight proteins that relocal-
ize to dysfunctional telomeres. However, it is important to note
that a number of known DNA damage proteins that have been
shown to play a crucial role in the response to telomere dysfunc-
tion were not identified in our analysis. Notably, RNF8 and
RNF168, which are required for the recruitment of 53BP1, are
missing from our isolations. This could be explained by the tran-
sient nature of the interaction between these ubiquitin ligases at
their DNA damage target sites. Nevertheless, the absence of
such critical factors represents a limitation of our approach
that most likely indicates the lack of other critical factors re-
cruited to dysfunctional telomeres. An additional limitation of
the PICh technique for this type of analysis is the requirement
for a very large amount of starting material for each individual
experiment (over 5 3 108 cells), which limits the number of con-
ditions and time points that can be tested. In addition, we found a
large number of contaminants in our isolations that overlap with
the commonly found contaminants in mass spectrometry exper-
iments (Mellacheruvu et al., 2013).
Despite these limitations, this approach represents an unbi-
ased identification of the dynamic changes of chromatin compo-
sition upon the onset of DNA damage. As such, the lists of
proteins that we identified will represent a valuable resource
not only to the telomere biology field but also to researchers
studying general DNA repair reactions and genome stability
pathways that act throughout the genome.
Finally, we have found a significant role for the polycomb
protein Ring1b in the onset of NHEJ at telomeres. These obser-
vations further substantiate previous observations of a role for
these factors in the response to DNA damage (Chagraouifunctional Telomeres
rase or shRing1b and Ring1b-WT* or Ring1b-I53A* and treated with OHT for
nts 5 mm.
nstructs directed against Bmi1 and treated with OHT for 96 hr. Percentages of
s quantification of relative Bmi1 mRNA levels measured by quantitative PCR,
nfected as described in (B), treated with OHT for 72 hr, and fixed and stained for
ive).
e TRF2 or a TRF2 dominant-negative allele (TRF2DBDM) as indicated and fixed
5 mm.
stained for telomeric DNA (green) to detect end-to-end chromosome fusions
with at least one fusion event are indicated. Scale bar represents 5 mm.
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Figure 5. Compact Chromatin Favors NHEJ-Mediated Repair of Dysfunctional Telomeres
(A) Confluent, stationary-phase Ring1bF/F Rosa26 CRE-ER MEFs untreated or treated with tamoxifen (/+ OHT) were left untreated (NT) or irradiated (2 Gy) and
harvested at the indicated time points postirradiation. ATM/MEFswere used as a control. Cells were fixed and stained for gH2AX (green) andDAPI (blue). Scale
bar represents 5 mm.
(B) Quantification of the total number of heterochromatin-associated gH2AX foci in cells treated as described in (A). Error bars represent SD of the average of
three independent experiments.
(legend continued on next page)
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et al., 2011; Chou et al., 2010; Facchino et al., 2010; Ginjala
et al., 2011; Ismail et al., 2010). Strikingly, however, our data
suggest that in the absence of Ring1b, the signaling events
downstream of ATM activation such as gH2AX and 53BP1
recruitment are not affected. These data are in agreement
with the observation that recruitment of 53BP1 is independent
of Ring1b-mediated H2A ubiquitylation (Gatti et al., 2012; Mat-
tiroli et al., 2012).
Our data suggest that Ring1b plays a critical role to maintain
a compact chromatin status that is permissive for NHEJ.
Indeed, previous reports have shown that compact chromatin
is more prone to undergo NHEJ-mediated DNA repair (Chiolo
et al., 2011; Miller et al., 2010). Ring1b activity in chromatin
compaction has been well established in the context of gene
expression at Hox loci (Eskeland et al., 2010). Notably, it has
been reported that the E3 activity of Ring1b is not required
for chromatin compaction, similarly to what we found in the
context of promotion of NHEJ at dysfunctional telomeres. We
found that treatment of cells with the HDAC inhibitor TSA re-
sulted in reduced levels of NHEJ at telomeres, thus further sug-
gesting that chromatin compaction is critical for NHEJ at
dysfunctional telomeres. Similarly, we found that reducing
H3K9me3 levels in cells depleted of TRF2, either by depletion
of Prdm3 or by the use of Suv39 dn MEFs, impaired the forma-
tion of NHEJ-mediated end-to-end chromosome fusions. These
results are in agreement with previous results showing a role for
HDAC1 and HDAC2 in NHEJ-dependent DNA repair at
genome-wide sites of DNA lesion (Miller et al., 2010) as well
as with the observation that TSA treatment shifts the repair
choice toward the homologous recombination pathway (Tang
et al., 2013). The heterochromatic status of telomeres would
therefore explain why telomere dysfunction preferentially trig-
gers NHEJ-mediated DNA repair and suggests that alterations
in chromatin status could be responsible for the increased ho-
mologous recombination observed at telomeres in tumors that
engage the alternative telomere-lengthening (ALT) pathway
(Cesare and Reddel, 2008). In line with this hypothesis,
increased rates of telomere sister chromatid exchange were
recently reported in ALT tumor cells subjected to TSA treatment
(Jung et al., 2013).
EXPERIMENTAL PROCEDURES
Telomeric Chromatin Isolation by PICh
Proteomics of isolated chromatin segments (PICh) was carried out as previ-
ously described (De´jardin and Kingston, 2009) with the following modifica-
tions: 5 3 108 MEFs were used per sample, and two sonication cycles were
performed using a Misonix S-4000 (first cycle, power 70%; second cycle,
power 40%). Each cycle consisted of 15 s on and 45 s off for a total process
time of 2 min. For hybridization with telomeric probe, a PNA probe (0.6 mM)
was used (desthiobiotin-112 atoms spacer-TTAGGGTTAGGGTTAGGGTT
AGGG) using the conditions described before, with the exception that denatur-
ation was carried out at 65C for 6 min.(C) Metaphase spreads of TRF2F/F Rosa26 CRE-ER MEFs treated with OHT for 7
ends are indicated. Scale bar represents 5 mm.
(D) Metaphase spreads of TRF2F/F Rosa26 CRE-ER MEFs infected with an shRN
OHT for 72 hr. Scale bar represents 5 mm.
(E) Model for the role of chromatin compaction in NHEJ-mediated repair of dysfu
See also Figure S5.
CMass Spectrometry Analysis
For mass spectrometry, analysis samples were denatured, reduced, and alky-
lated prior to an overnight digestion with trypsin. Peptide mixtures were
analyzed by nanoflow liquid chromatography mass spectrometry using an
Eksigent nanopump and LTQ-Orbitrap mass spectrometer (Thermo Scientific)
using a seven-step MudPIT separation. TandemMS spectra were collected in
a data-dependent fashion, and resulting spectra were extracted using
RawXtract. Protein identification was done with Integrated Proteomics Pipe-
line (IP2) by searching against UniProt Human database and filtering to 1%
false positive at the spectrum level using DTASelect.
MEFs and shRNA Infections
TRF2F/F Rosa26 CRE-ER MEFs were previously described (Okamoto et al.,
2013). Ring1bF/F Rosa CRE ER MEFs were derived from a cross between
Ring1b conditional mice (de Napoles et al., 2004) and Rosa26 CRE-ER mice
(Ventura et al., 2007). CRE activation was obtained treating cells with 4-hy-
droxytamoxifen (OHT) at a final concentration of 0.6 mM. Suv39 dn immortal-
ized MEFs (iMEFs) and wild-type control iMEFs were a kind gift from T.
Jenuwein.
shRNAs were cloned into the pLKO-puromycin lentiviral vector (for se-
quences see Supplemental Experimental Procedures). shRNA infections
were performed as previously described (Okamoto et al., 2013). Knockdown
efficiency was analyzed by quantitative PCR using Roche Sybr Green Master-
mix according to the manufacturer’s instructions on a LightCycler 480 II
(Roche).
Immunofluorescence, IF-FISH, ChIP, and Immunoblotting
Immunoblots and IF were performed using the protocols described previously
(Celli and de Lange, 2005). For Ring1b detection by immunoblot, extracts were
prepared according to Vella et al. (2013). For IF, where indicated cells were
permeabilized with Triton X-100 buffer (for details, see the Supplemental
Experimental Procedures). Fluorescence in situ hybridization immunofluores-
cence (FISH-IF) staining was performed using the protocol developed by
Sedivy and colleagues (Herbig et al., 2004). For quantification, at least 100
cells were counted following FISH-IF analysis. Cells with at least five foci
colocalizing with telomere DNA or TRF1 were scored as positive. Error bars
indicate SDs and derive from averages of three independent experiments.
p values were calculated using the Student’s t test.
ChIP experiments were performed as described previously (Loayza and De
Lange, 2003; O’Sullivan et al., 2010; Ye and de Lange, 2004). Full details of all
other experimental procedures are given in the Supplemental Experimental
Procedures.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2014.04.002.
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